Company · Mississauga, Ontario, Canada
Gilead Sciences Canada Inc
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 34
- 28 authorized now
- Natural health products
- 0
- 0 active licences
- Medical device licences
- 0
- 0 active
- Notices of Compliance
- 167
Drug products
Authorized products first.
| Name | DIN | Status | Status since |
|---|---|---|---|
| BIKTARVYStatus since Aug 2018 | 02478579 | Marketed | |
| CAYSTONStatus since May 2011 | 02329840 | Marketed | |
| COMPLERAStatus since Oct 2014 | 02374129 | Marketed | |
| DESCOVYStatus since Jun 2016 | 02454416 | Marketed | |
| DESCOVYStatus since Jun 2016 | 02454424 | Marketed | |
| EPCLUSAStatus since Aug 2016 | 02456370 | Marketed | |
| GENVOYAStatus since Feb 2016 | 02449498 | Marketed | |
| HARVONIStatus since Oct 2014 | 02432226 | Marketed | |
| HEPCLUDEXStatus since Oct 2025 | 02560178 | Marketed | |
| LYVDELZIStatus since Nov 2025 | 02561492 | Marketed | |
| ODEFSEYStatus since Mar 2017 | 02461463 | Marketed | |
| SOVALDIStatus since Jan 2014 | 02418355 | Marketed | |
| STRIBILDStatus since Dec 2012 | 02397137 | Marketed | |
| SUNLENCAStatus since Mar 2023 | 02532468 | Marketed | |
| SUNLENCAStatus since Mar 2023 | 02532476 | Marketed | |
| TECARTUSStatus since Dec 2021 | 02516667 | Marketed | |
| TECARTUSStatus since Dec 2023 | 02532719 | Marketed | |
| TRODELVYStatus since Nov 2021 | 02520788 | Marketed | |
| TRUVADAStatus since May 2009 | 02274906 | Marketed | |
| VEKLURYStatus since Oct 2020 | 02502143 | Marketed | |
| VEMLIDYStatus since Jun 2017 | 02464241 | Marketed | |
| VIREADStatus since May 2009 | 02247128 | Marketed | |
| VOSEVIStatus since Sep 2017 | 02467542 | Marketed | |
| YESCARTAStatus since Nov 2019 | 02485648 | Marketed | |
| ZYDELIGStatus since Apr 2015 | 02438798 | Marketed | |
| ZYDELIGStatus since Apr 2015 | 02438801 | Marketed | |
| YEYTUOStatus since Apr 2026 | 02567202 | Approved | |
| YEYTUOStatus since Apr 2026 | 02567210 | Approved | |
| EMTRIVAStatus since Apr 2026 | 02272091 | Cancelled Post Market | |
| HEPSERAStatus since Dec 2022 | 02247823 | Cancelled Post Market | |
| TYBOSTStatus since Jul 2025 | 02411423 | Cancelled Post Market | |
| VEKLURYStatus since Apr 2021 | 02502135 | Cancelled Pre Market | |
| VITEKTAStatus since Jan 2017 | 02411172 | Cancelled Post Market | |
| VITEKTAStatus since Jan 2017 | 02411180 | Cancelled Post Market |
Notices of Compliance
Newest first.
- YESCARTASeptember 24, 2026 · NOC 38338 · Supplement to a New Drug Submission (SNDS)
- YESCARTAAugust 27, 2026 · NOC 38187 · Supplement to a New Drug Submission (SNDS)
- SUNLENCAAugust 12, 2026 · NOC 38104 · Supplement to a New Drug Submission (SNDS)
- YESCARTAJuly 8, 2026 · NOC 37854 · Supplement to a New Drug Submission (SNDS)
- TRODELVYJuly 8, 2026 · NOC 37855 · Supplement to a New Drug Submission (SNDS)
- HEPCLUDEXMay 14, 2026 · NOC 37557 · Supplement to a New Drug Submission (SNDS)
- YEYTUOApril 9, 2026 · NOC 37292 · New Drug Submission (NDS)
- LYVDELZIOctober 16, 2025 · NOC 36189 · New Drug Submission (NDS)
- SUNLENCAAugust 29, 2025 · NOC 35933 · Supplement to a New Drug Submission (SNDS)
- HEPCLUDEXAugust 8, 2025 · NOC 35802 · New Drug Submission (NDS)
- VEKLURYAugust 6, 2025 · NOC 35798 · Supplement to a New Drug Submission (SNDS)
- SUNLENCAJuly 21, 2025 · NOC 35701 · Supplement to a New Drug Submission (SNDS)
- TECARTUSJune 26, 2025 · NOC 35648 · Supplement to a New Drug Submission (SNDS)
- YESCARTAJune 24, 2025 · NOC 35589 · Supplement to a New Drug Submission (SNDS)
- VEMLIDYJune 12, 2025 · NOC 35509 · Supplement to a New Drug Submission (SNDS)
- VIREADJune 11, 2025 · NOC 35501 · Supplement to a New Drug Submission (SNDS)
- BIKTARVYJune 10, 2025 · NOC 35488 · Supplement to a New Drug Submission (SNDS)
- ZYDELIGMay 28, 2025 · NOC 35438 · Supplement to a New Drug Submission (SNDS)
- YESCARTAMay 23, 2025 · NOC 35412 · Supplement to a New Drug Submission (SNDS)
- TRODELVYMay 14, 2025 · NOC 35349 · Supplement to a New Drug Submission (SNDS)
- STRIBILDMay 8, 2025 · NOC 35320 · Supplement to a New Drug Submission (SNDS)
- SOVALDIMay 8, 2025 · NOC 35322 · Supplement to a New Drug Submission (SNDS)
- HARVONIMay 8, 2025 · NOC 35323 · Supplement to a New Drug Submission (SNDS)
- COMPLERAApril 11, 2025 · NOC 35176 · Supplement to a New Drug Submission (SNDS)
- EPCLUSAApril 10, 2025 · NOC 35164 · Supplement to a New Drug Submission (SNDS)
- VEKLURYApril 3, 2025 · NOC 35117 · Supplement to a New Drug Submission (SNDS)
- ODEFSEYMarch 14, 2025 · NOC 35016 · Supplement to a New Drug Submission (SNDS)
- VOSEVIMarch 7, 2025 · NOC 34978 · Supplement to a New Drug Submission (SNDS)
- CAYSTONFebruary 25, 2025 · NOC 34907 · Supplement to a New Drug Submission (SNDS)
- BIKTARVYFebruary 4, 2025 · NOC 34792 · Supplement to a New Drug Submission (SNDS)
- TRUVADAJanuary 22, 2025 · NOC 34724 · Supplement to a New Drug Submission (SNDS)
- CAYSTONDecember 17, 2024 · NOC 34563 · Supplement to a New Drug Submission (SNDS)
- GENVOYADecember 5, 2024 · NOC 34493 · Supplement to a New Drug Submission (SNDS)
- DESCOVYNovember 25, 2024 · NOC 34444 · Supplement to a New Drug Submission (SNDS)
- SUNLENCAOctober 31, 2024 · NOC 34312 · Supplement to a New Drug Submission (SNDS)
- BIKTARVYOctober 31, 2024 · NOC 34314 · Supplement to a New Drug Submission (SNDS)
- YESCARTAJune 18, 2024 · NOC 33169 · Supplement to a New Drug Submission (SNDS)
- TECARTUSJune 18, 2024 · NOC 33472 · Supplement to a New Drug Submission (SNDS)
- TECARTUSJune 17, 2024 · NOC 33459 · Supplement to a New Drug Submission (SNDS)
- YESCARTAMay 17, 2024 · NOC 33263 · Supplement to a New Drug Submission (SNDS)
- VEKLURYMay 6, 2024 · NOC 33184 · Supplement to a New Drug Submission (SNDS)
- VEKLURYFebruary 6, 2024 · NOC 32653 · Supplement to a New Drug Submission (SNDS)
- YESCARTAJanuary 9, 2024 · NOC 32523 · Supplement to a New Drug Submission (SNDS)
- VEKLURYNovember 17, 2023 · NOC 32167 · Supplement to a New Drug Submission (SNDS)
- TRODELVYNovember 10, 2023 · NOC 32076 · Supplement to a New Drug Submission (SNDS)
- TECARTUSOctober 19, 2023 · NOC 31903 · Supplement to a New Drug Submission (SNDS)
- TRODELVYJuly 19, 2023 · NOC 31246 · Supplement to a New Drug Submission (SNDS)
- VEKLURYJune 15, 2023 · NOC 31004 · Supplement to a New Drug Submission (SNDS)
- BIKTARVYApril 14, 2023 · NOC 30548 · Supplement to a New Drug Submission (SNDS)
- TECARTUSMarch 23, 2023 · NOC 30367 · Supplement to a New Drug Submission (SNDS)
- TRODELVYJanuary 20, 2023 · NOC 29966 · Supplement to a New Drug Submission (SNDS)
- YESCARTADecember 6, 2022 · NOC 29655 · Supplement to a New Drug Submission (SNDS)
- TECARTUSNovember 16, 2022 · NOC 29485 · Supplement to a New Drug Submission (SNDS)
- SUNLENCANovember 2, 2022 · NOC 29368 · New Drug Submission (NDS)
- VEKLURYOctober 14, 2022 · NOC 29215 · Supplement to a New Drug Submission (SNDS)
- YESCARTAOctober 13, 2022 · NOC 29213 · Supplement to a New Drug Submission (SNDS)
- TRODELVYOctober 5, 2022 · NOC 29149 · Supplement to a New Drug Submission (SNDS)
- CAYSTONSeptember 29, 2022 · NOC 29137 · Supplement to a New Drug Submission (SNDS)
- YESCARTASeptember 28, 2022 · NOC 29096 · Supplement to a New Drug Submission (SNDS)
- EPCLUSAAugust 11, 2022 · NOC 28748 · Supplement to a New Drug Submission (SNDS)
- DESCOVYAugust 9, 2022 · NOC 28734 · Supplement to a New Drug Submission (SNDS)
- HEPSERAMay 20, 2022 · NOC 28237 · Supplement to a New Drug Submission (SNDS)
- VEKLURYApril 22, 2022 · NOC 28009 · Supplement to a New Drug Submission (SNDS)
- VEKLURYJanuary 24, 2022 · NOC 27455 · Supplement to an Abbreviated New Drug Submission (SANDS)
- VEKLURYNovember 23, 2021 · NOC 27085 · Supplement to a New Drug Submission (SNDS)
- BIKTARVYNovember 2, 2021 · NOC 26953 · Supplement to a New Drug Submission (SNDS)
- VOSEVIOctober 8, 2021 · NOC 26808 · Supplement to a New Drug Submission (SNDS)
- EPCLUSAOctober 6, 2021 · NOC 26790 · Supplement to a New Drug Submission (SNDS)
- TRODELVYSeptember 24, 2021 · NOC 26736 · New Drug Submission (NDS)
- TYBOSTAugust 18, 2021 · NOC 26460 · Supplement to a New Drug Submission (SNDS)
- VEKLURYAugust 12, 2021 · NOC 26442 · Supplement to a New Drug Submission (SNDS)
- GENVOYAAugust 9, 2021 · NOC 26405 · Supplement to a New Drug Submission (SNDS)
- STRIBILDJuly 27, 2021 · NOC 26335 · Supplement to a New Drug Submission (SNDS)
- HARVONIJune 25, 2021 · NOC 26148 · Supplement to a New Drug Submission (SNDS)
- SOVALDIJune 25, 2021 · NOC 26149 · Supplement to a New Drug Submission (SNDS)
- EPCLUSAJune 25, 2021 · NOC 26150 · Supplement to a New Drug Submission (SNDS)
- TECARTUSJune 8, 2021 · NOC 26027 · New Drug Submission (NDS)
- BIKTARVYMay 21, 2021 · NOC 25904 · Supplement to a New Drug Submission (SNDS)
- VOSEVIMay 21, 2021 · NOC 25927 · Supplement to a New Drug Submission (SNDS)
- VOSEVIApril 16, 2021 · NOC 25693 · Supplement to a New Drug Submission (SNDS)
- VEKLURYMarch 2, 2021 · NOC 25330 · Supplement to a New Drug Submission (SNDS)
- BIKTARVYFebruary 5, 2021 · NOC 25161 · Supplement to a New Drug Submission (SNDS)
- BIKTARVYDecember 30, 2020 · NOC 24911 · Supplement to a New Drug Submission (SNDS)
- YESCARTADecember 22, 2020 · NOC 24886 · Supplement to a New Drug Submission (SNDS)
- STRIBILDDecember 4, 2020 · NOC 24739 · Supplement to a New Drug Submission (SNDS)
- DESCOVYNovember 27, 2020 · NOC 24690 · Supplement to a New Drug Submission (SNDS)
- GENVOYANovember 16, 2020 · NOC 24626 · Supplement to a New Drug Submission (SNDS)
- EPCLUSANovember 6, 2020 · NOC 24569 · Supplement to a New Drug Submission (SNDS)
- VEMLIDYAugust 21, 2020 · NOC 24090 · Supplement to a New Drug Submission (SNDS)
- HEPSERAAugust 20, 2020 · NOC 24087 · Supplement to a New Drug Submission (SNDS)
- ZYDELIGAugust 19, 2020 · NOC 24080 · Supplement to a New Drug Submission (SNDS)
- VEKLURYJuly 27, 2020 · NOC 23963 · New Drug Submission (NDS)
- ZYDELIGApril 21, 2020 · NOC 23491 · Supplement to a New Drug Submission (SNDS)
- BIKTARVYApril 14, 2020 · NOC 23451 · Supplement to a New Drug Submission (SNDS)
- YESCARTAMarch 18, 2020 · NOC 23364 · Supplement to a New Drug Submission (SNDS)
- BIKTARVYMarch 2, 2020 · NOC 23293 · Supplement to a New Drug Submission (SNDS)
- HARVONIFebruary 4, 2020 · NOC 23170 · Supplement to a New Drug Submission (SNDS)
- VOSEVIJanuary 28, 2020 · NOC 23158 · Supplement to a New Drug Submission (SNDS)
- EPCLUSAJanuary 16, 2020 · NOC 23108 · Supplement to a New Drug Submission (SNDS)
- ODEFSEYOctober 25, 2019 · NOC 22831 · Supplement to a New Drug Submission (SNDS)
The latest 100 of 167.
Recalls and safety alerts that mention its products
Health Canada’s recall notices do not carry licence numbers, so these are matched by name. A notice may cover another product or only some lots: read it to see what it covers.
- Important Safety Information on Yescarta (axicabtagene ciloleucel) and the Risk of Cerebral Edema in Primary Mediastinal B Cell Lymphoma (PMBCL)December 10, 2025 · Biologic or vaccine · New safety information
- Two lots of cystic fibrosis drug Cayston recalled due to the potential of cracked glass vialsMarch 20, 2023 · Drugs · Product quality
- CAYSTON: Vials may be cracked in affected lotsMarch 3, 2023 · Drugs · Product quality · Type I
- ZYDELIG (idelalisib) - Increased Risk of Fatal and Serious InfectionsMay 3, 2016 · Drugs · Product safety
- Archived – Conditional Approval of Viread (Tenofovir Disoproxil Fumarate) – Gilead Sciences, Inc.May 10, 2004 · Health products · Product safety